Lpwm LLC Buys Shares of 2,063 Cencora, Inc. $COR

Lpwm LLC bought a new stake in Cencora, Inc. (NYSE:COR) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 2,063 shares of the company’s stock, valued at approximately $697,000.

Other large investors have also modified their holdings of the company. IAG Wealth Partners LLC purchased a new position in Cencora in the 3rd quarter valued at $30,000. Cloud Capital Management LLC acquired a new position in Cencora in the 3rd quarter valued at $31,000. Caitlin John LLC purchased a new position in Cencora during the 3rd quarter worth $31,000. Vermillion & White Wealth Management Group LLC lifted its stake in shares of Cencora by 69.4% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after acquiring an additional 43 shares during the period. Finally, Westside Investment Management Inc. lifted its stake in shares of Cencora by 200.0% in the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock worth $33,000 after acquiring an additional 70 shares during the period. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Buying and Selling at Cencora

In related news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares of the company’s stock, valued at $23,669,713.98. This trade represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.38% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on COR shares. Morgan Stanley set a $380.00 price target on shares of Cencora in a research note on Tuesday. Barclays raised their price objective on shares of Cencora from $400.00 to $425.00 and gave the company an “overweight” rating in a research report on Friday, February 13th. JPMorgan Chase & Co. lifted their price objective on Cencora from $417.00 to $419.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Evercore reissued an “outperform” rating on shares of Cencora in a research note on Tuesday. Finally, Leerink Partners reissued an “outperform” rating on shares of Cencora in a report on Tuesday. Twelve equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $403.17.

Cencora Stock Performance

Shares of COR opened at $332.06 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. Cencora, Inc. has a 52-week low of $264.33 and a 52-week high of $377.54. The company has a 50-day simple moving average of $355.08 and a 200-day simple moving average of $339.36. The company has a market capitalization of $64.59 billion, a PE ratio of 39.91, a P/E/G ratio of 1.51 and a beta of 0.68.

Cencora (NYSE:COR) last released its quarterly earnings data on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping analysts’ consensus estimates of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm had revenue of $85.93 billion for the quarter, compared to the consensus estimate of $86.12 billion. During the same quarter in the previous year, the firm earned $3.73 earnings per share. The firm’s revenue was up 5.5% on a year-over-year basis. Equities research analysts predict that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Stockholders of record on Friday, February 13th were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $2.40 annualized dividend and a dividend yield of 0.7%. Cencora’s payout ratio is 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.